Vir Biotechnology, Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Vir Biotechnology, Inc. filed 47 open-market sales worth $14.7 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Napolitano Janet, Director, sold 3,200 shares at $9.45 on 1 June 2026, filed 2 June 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 1 June 2026 | Napolitano Janet | Director | Sale | 3,200 | $9.45 | $30,240 | Form 4 |
| 1 June 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sale | 379 | $9.45 | $3,582 | Form 4 |
| 1 May 2026 | Sato Vicki L | Director | Sale | 22,000 | $10.05 | $221,025 | Form 4 |
| 6 April 2026 | De Backer Marianne | President and CEO | Sale | 72,559 | $9.16 | $664,350 | Form 4 |
| 1 April 2026 | Sato Vicki L | Director | Sale | 22,000 | $9.07 | $199,617 | Form 4 |
| 23 March 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sale | 7,711 | $9.12 | $70,324 | Form 4 |
| 2 March 2026 | Sato Vicki L | Director | Sale | 21,800 | $9.50 | $207,185 | Form 4 |
| 2 March 2026 | Sato Vicki L | Director | Sale | 200 | $9.98 | $1,996 | Form 4 |
| 25 February 2026 | Eisner Mark | EVP and Chief Medical Officer | Sale | 1,889 | $9.82 | $18,550 | Form 4 |
| 25 February 2026 | De Verneuil Vanina | EVP, General Counsel, Corp Sec | Sale | 13,700 | $9.82 | $134,534 | Form 4 |
| 24 February 2026 | Sato Vicki L | Director | Sale | 42,177 | $9.75 | $411,314 | Form 4 |
| 24 February 2026 | Sato Vicki L | Director | Sale | 200 | $10.26 | $2,052 | Form 4 |
| 24 February 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sale | 1,430 | $9.53 | $13,632 | Form 4 |
| 24 February 2026 | O'Byrne Jason | EVP & Chief Financial Officer | Sale | 1,634 | $9.53 | $15,576 | Form 4 |
| 24 February 2026 | Eisner Mark | EVP and Chief Medical Officer | Sale | 1,616 | $9.53 | $15,405 | Form 4 |
| 24 February 2026 | De Verneuil Vanina | EVP, General Counsel, Corp Sec | Sale | 3,117 | $9.53 | $29,713 | Form 4 |
| 24 February 2026 | De Backer Marianne | Chief Executive Officer | Sale | 14,762 | $9.53 | $140,720 | Form 4 |
| 23 February 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sale | 1,829 | $7.45 | $13,631 | Form 4 |
| 23 February 2026 | O'Byrne Jason | EVP & Chief Financial Officer | Sale | 2,089 | $7.45 | $15,569 | Form 4 |
| 23 February 2026 | Eisner Mark | EVP and Chief Medical Officer | Sale | 2,089 | $7.45 | $15,569 | Form 4 |
| 23 February 2026 | De Verneuil Vanina | EVP, General Counsel, Corp Sec | Sale | 4,445 | $7.45 | $33,128 | Form 4 |
| 23 February 2026 | De Backer Marianne | Chief Executive Officer | Sale | 19,039 | $7.45 | $141,894 | Form 4 |
| 13 February 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sale | 1,530 | $7.79 | $11,919 | Form 4 |
| 2 February 2026 | Sato Vicki L | Director | Sale | 22,000 | $7.71 | $169,671 | Form 4 |
| 2 January 2026 | Sato Vicki L | Director | Sale | 22,000 | $5.93 | $130,383 | Form 4 |
| 1 December 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 191,854 | $5.98 | $1.1 million | Form 4 |
| 1 December 2025 | Sato Vicki L | Director | Sale | 22,000 | $6.00 | $132,070 | Form 4 |
| 28 November 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 61,493 | $6.44 | $396,015 | Form 4 |
| 26 November 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 127,938 | $6.39 | $817,652 | Form 4 |
| 25 November 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 235,971 | $6.38 | $1.5 million | Form 4 |
| 24 November 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 227,803 | $6.15 | $1.4 million | Form 4 |
| 17 November 2025 | O'Byrne Jason | EVP & Chief Financial Officer | Sale | 6,799 | $5.56 | $37,782 | Form 4 |
| 5 November 2025 | De Verneuil Vanina | EVP, General Counsel, Corp Sec | Sale | 2,385 | $5.16 | $12,307 | Form 4 |
| 3 November 2025 | De Verneuil Vanina | EVP and General Counsel | Sale | 1,365 | $5.86 | $8,003 | Form 4 |
| 3 November 2025 | Sato Vicki L | Director | Sale | 22,000 | $5.64 | $124,047 | Form 4 |
| 29 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 100 | $6.49 | $649 | Form 4 |
| 28 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 24,453 | $6.50 | $159,006 | Form 4 |
| 27 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 66,403 | $6.05 | $401,585 | Form 4 |
| 24 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 46,696 | $5.96 | $278,285 | Form 4 |
| 23 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 154,383 | $5.99 | $924,723 | Form 4 |
| 22 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 144,266 | $6.15 | $887,654 | Form 4 |
| 21 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 109,675 | $6.30 | $690,974 | Form 4 |
| 20 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 220,535 | $6.20 | $1.4 million | Form 4 |
| 16 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 12,844 | $6.10 | $78,366 | Form 4 |
| 15 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 16,671 | $6.07 | $101,196 | Form 4 |
| 10 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 2,300 | $6.08 | $13,973 | Form 4 |
| 9 October 2025 | Svf Endurance (Cayman) Ltd | 10% owner | Sale | 249,060 | $6.14 | $1.5 million | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Vir Biotechnology, Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.